Multistate model for pharmacometric analyses of overall survival in HER2‐negative breast cancer patients treated with docetaxel

Multistate model for pharmacometric analyses of overall survival in HER2‐negative breast cancer patients treated with docetaxel

Abstract The aim of this study was to develop a multistate model for overall survival (OS) analysis, based on parametric hazard functions and combined with an investigation of predictors derived from a longitudinal tumor size model on the transition hazards. Different states – stable disease, tumor...

Full description

Bibliographic Details
Main Authors: Sreenath M. Krishnan, Lena E. Friberg, René Bruno, Ulrich Beyer, Jin Y. Jin, Mats O. Karlsson
Format: Article
Language:English
Published: Wiley 2021-10-01
Series:CPT: Pharmacometrics & Systems Pharmacology
Online Access:https://doi.org/10.1002/psp4.12693

Similar Items

Similar Items